Mounjaro and alcohol: what the leaflets say, and the studies

Search for the word "alcohol" in the product information for Mounjaro (tirzepatide) and it turns up only in connection with benzyl alcohol, an ingredient of the pen. On wine with dinner or a pint on a Friday, not a line. The documents for Wegovy and Ozempic (semaglutide) are just as silent. Yet "Mounjaro and alcohol" is asked about constantly, and for two opposite reasons: some people want to know whether they can still raise a glass, others are puzzled that they no longer want to.

A leaflet's silence is not permission. It means that regulators have not identified a direct interaction between these medicines and alcohol. It says nothing about how alcohol combines with their side effects, and that is where everything is decided.

Can you drink alcohol on Mounjaro?

No official text forbids it, and none says it is without consequence. The UK product information for Mounjaro, Wegovy and Ozempic lists alcohol neither among the contraindications nor among the interactions. The interactions section deals with medicines taken by mouth, whose absorption can be altered by the slowing of the stomach.

So the answer depends on the person: on whether they have diabetes, on their other medicines, on how well they are tolerating the jab. It is a question to put to your prescriber or pharmacist. What follows should help make sense of the reply.

Mounjaro and alcohol: three reasons to go easy

The first is the stomach. Tirzepatide and semaglutide both delay gastric emptying, and nausea is among their very common side effects, especially in the weeks when the dose is going up. Alcohol irritates the stomach lining and causes nausea in its own right. The two add up. The product information also stresses the risk of dehydration when vomiting or diarrhoea occur, and alcohol makes you lose fluid.

The second concerns blood sugar, and applies first to people with diabetes. The Mounjaro product information classes hypos as very common when the medicine is combined with a sulfonylurea or insulin. Alcohol is known to lower blood glucose, particularly when drunk on an empty stomach, and a small appetite makes a drink without a meal more likely. The signs of a hypo, drowsiness, confusion and dizziness, also look a good deal like being drunk, which can delay the people around you from reacting.

The third involves the pancreas. Cases of acute pancreatitis have been reported with both tirzepatide and semaglutide; the effect is classed as uncommon, and the MHRA strengthened its warning in January 2026. Alcohol, for its part, is a classic cause of pancreatitis. No study shows that the two risks multiply; caution says not to stack them. Severe, persistent stomach pain that may spread to the back needs urgent medical attention, drink or no drink.

Some patients also say alcohol hits them differently, faster or for longer. With a slowed stomach and a falling body weight, that is plausible. We found no study that has measured it, so it stays in the category of anecdote.

The urge to drink that fades

This is the unexpected side of the subject. As early as 2023, researchers at Virginia Tech analysed posts on Reddit about semaglutide and tirzepatide. Of the 1,580 that mentioned alcohol, 71% described less desire to drink, a weaker craving or unpleasant effects. The same team then questioned 153 people living with obesity: those taking one of these medicines reported drinking less than before, and less than the group not on treatment. The study appeared in Scientific Reports. It relies on what people say about themselves, and that is its limit.

The research has multiplied since, with uneven levels of evidence.

The first two are observational: they record an association without proving that the medicine is the cause. The last two are placebo-controlled trials, sturdier but small, run in people with alcohol use disorder. A meta-analysis published in late 2025 in Addiction Science & Clinical Practice, before the Lancet trial, concluded that the randomised trials then available did not, taken together, show a significant fall in consumption.

One detail matters for anyone on Mounjaro. The randomised trials we were able to verify concern semaglutide and an older molecule, exenatide. For tirzepatide, the published data are still self-reported or observational.

Why the glass loses its appeal

The best-studied hypothesis runs through the brain's reward circuit. In a Danish trial published in JCI Insight, exenatide did not reduce the number of heavy drinking days compared with placebo. Brain imaging did, however, show that reward regions responded less to pictures of alcohol in the treated patients. The mechanism would be close to the one that dulls the pull of food.

None of this makes these medicines a treatment for alcohol dependence. None is licensed for that purpose, and anyone worried about their drinking has every reason to speak to their GP or a local alcohol support service, whether they are on treatment or not.

Alcohol and weight loss

A gram of alcohol supplies 7 kcal, almost as much as a gram of fat. In UK terms, one unit is 8g of pure alcohol. A 175ml glass of 12% wine holds 2.1 units according to the NHS, which makes close to 120 kcal from the alcohol alone, before counting the sugars in beer, sweet wine or a cocktail. Those calories do not fill you up and bring neither protein nor fibre.

On treatment, appetite is rationed. Every drink takes the place of a food the body has more use for, starting with protein, which contributes to the maintenance of muscle mass. No study has measured the effect of alcohol on the weight lost with these medicines; the reasoning is the same as in any period of weight loss. Our GLP-1 diet guide returns to those priorities.

A few benchmarks that hold for everyone

The UK Chief Medical Officers advise men and women not to drink more than 14 units a week on a regular basis, to spread them over three or more days, and to keep several days drink-free. Fourteen units is roughly six pints of average-strength beer or ten small glasses of wine. These are low-risk limits for the general population. They were not drawn up with people on GLP-1 medicines in mind, and your prescriber may advise staying well below them.

A few habits are sound at any time and take on more weight here: do not drink on an empty stomach, alternate with water, drink slowly. The weeks when the dose is rising are the ones when digestive side effects are most frequent, and so the ones when alcohol goes down worst.

Some people have good reason to abstain altogether during treatment, for instance those on insulin or a sulfonylurea, or those with a history of pancreatitis or liver disease. That is a decision to make with a doctor. The rest of what to look out for is in our guide to GLP-1 side effects and in the articles on Mounjaro side effects and Wegovy side effects.

This article is for information only and is no substitute for advice from a healthcare professional. Never change your treatment without talking to your doctor.